[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis.

Ephraim E ParentDhruv PatelJonathon A NyeZhuo LiJeffrey J OlsonDavid M SchusterMark M Goodman

Published in: EJNMMI research (2020)

Fluciclovine PET may play an important role in distinguishing active intracranial metastatic lesions from radiation necrosis in patients previously treated with SRS but needs to be validated in larger studies.

Keyphrases

pet ct
end stage renal disease
squamous cell carcinoma
small cell lung cancer
newly diagnosed
computed tomography
ejection fraction
positron emission tomography
chronic kidney disease
radiation induced
radiation therapy
patient reported outcomes